Drug Approval | April 24, 2023
Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Fully equipped labs with 75-member team set-up and made operational in <100 days
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Healthcare leaders are heavily investing in AI or plan to do so for both critical decision support and operational efficiency, helping tackle staff shortages
Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of USD 1.9 mn in the United States
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
Subscribe To Our Newsletter & Stay Updated
